NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market on Thursday that its third-quarter revenues more than doubled due to grant and contract revenues and its net loss dropped 9 percent.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $729,000 for the three-month period ended Sept. 30, compared to $283,000 for the prior year third quarter. Its contract and grant revenues were roughly $422,000 for the quarter compared to $73,000 the year before, while its product sales grew to $307,000 from $210,000 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.